TVTX- Travere Therapeutics, Inc.

TVTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Dube Eric M	432.9K	$26.07M	-
Other	Heerma Peter	138.6K	$8.35M	-
Other	Rote William E.	123.1K	$7.41M	-
CFO	Cline Christopher R.	116.9K	$7.04M	-
Other	Inrig Jula	111.5K	$6.71M	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 15, 2026	Inrig Jula	Chief Medical Officer	Sell	8,233	$42.01	$345,893.27	-3.5%	+39.3%	-
Apr 15, 2026	Reed Elizabeth E57	Chief Legal Officer And GC	Sale+OE	51,500	$41.29	$2,126,451.68	-10.4%	+39.3%	-
Apr 15, 2026	Cline Christopher R.48	Chief Financial Officer	Sell	8,327	$41.91	$348,974.00	-1.7%	+39.3%	-
Apr 15, 2026	Dube Eric M56	Chief Executive Officer	Sell	64,000	$41.09	$2,629,975.10	-4.7%	+39.3%	-
Apr 14, 2026	Heerma Peter53	Chief Commercial Officer	Sell	7,215	$41.93	$302,516.29	-4.9%	+34.3%	-
Feb 3, 2026	Inrig Jula	Chief Medical Officer	Sell	6,956	$32.12	$223,426.72	-6.1%	+34.3%	-
Feb 3, 2026	Calvin Sandra60	SVP, Chief Accounting Officer	Sell	4,333	$32.12	$139,175.96	-8.1%	+34.3%	-
Feb 3, 2026	Reed Elizabeth E57	Chief Legal Officer And GC	Sell	7,175	$32.12	$230,461.00	-6.2%	+34.3%	-
Feb 3, 2026	Dube Eric M56	Chief Executive Officer	Sell	100,087	$32.28	$3,230,315.62	-10.0%	+34.3%	-
Feb 3, 2026	Cline Christopher R.48	Chief Financial Officer	Sell	7,242	$32.12	$232,613.04	-6.0%	+34.3%	-